Focus Partners Wealth Sells 18,538 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Focus Partners Wealth cut its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 25.9% in the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 53,036 shares of the medical equipment provider’s stock after selling 18,538 shares during the quarter. Focus Partners Wealth’s holdings in Intuitive Surgical were worth $27,683,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also modified their holdings of the business. Vanguard Group Inc. grew its position in shares of Intuitive Surgical by 1.1% in the 4th quarter. Vanguard Group Inc. now owns 32,212,196 shares of the medical equipment provider’s stock valued at $16,813,478,000 after purchasing an additional 360,591 shares during the period. Geode Capital Management LLC grew its position in shares of Intuitive Surgical by 3.2% in the 4th quarter. Geode Capital Management LLC now owns 7,756,727 shares of the medical equipment provider’s stock valued at $4,039,200,000 after purchasing an additional 243,802 shares during the period. Fisher Asset Management LLC grew its position in shares of Intuitive Surgical by 1.8% in the 4th quarter. Fisher Asset Management LLC now owns 4,868,869 shares of the medical equipment provider’s stock valued at $2,541,356,000 after purchasing an additional 86,488 shares during the period. Norges Bank bought a new stake in Intuitive Surgical in the 4th quarter valued at approximately $2,401,493,000. Finally, Invesco Ltd. lifted its stake in Intuitive Surgical by 7.7% in the 4th quarter. Invesco Ltd. now owns 4,148,180 shares of the medical equipment provider’s stock valued at $2,165,184,000 after acquiring an additional 295,025 shares in the last quarter. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity at Intuitive Surgical

In related news, EVP Robert Desantis sold 11,545 shares of the stock in a transaction on Thursday, March 13th. The stock was sold at an average price of $499.22, for a total value of $5,763,494.90. Following the sale, the executive vice president now owns 5,224 shares in the company, valued at approximately $2,607,925.28. This represents a 68.85% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, VP Fredrik Widman sold 810 shares of the stock in a transaction on Monday, March 3rd. The shares were sold at an average price of $573.78, for a total value of $464,761.80. Following the completion of the sale, the vice president now owns 473 shares in the company, valued at approximately $271,397.94. This trade represents a 63.13% decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 33,044 shares of company stock worth $17,070,433. Company insiders own 0.70% of the company’s stock.

Intuitive Surgical Stock Down 0.3%

Shares of Intuitive Surgical stock opened at $536.55 on Monday. Intuitive Surgical, Inc. has a 12-month low of $379.67 and a 12-month high of $616.00. The stock has a market cap of $192.31 billion, a P/E ratio of 83.71, a P/E/G ratio of 5.85 and a beta of 1.70. The business’s 50 day moving average is $500.93 and its 200-day moving average is $535.03.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share for the quarter, beating analysts’ consensus estimates of $1.71 by $0.10. Intuitive Surgical had a return on equity of 14.55% and a net margin of 27.81%. The business had revenue of $2.25 billion for the quarter, compared to analysts’ expectations of $2.19 billion. During the same quarter in the prior year, the business earned $1.50 EPS. On average, sell-side analysts expect that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Analysts Set New Price Targets

ISRG has been the topic of several research reports. Citigroup boosted their target price on Intuitive Surgical from $640.00 to $711.00 and gave the company a “buy” rating in a research note on Friday, January 24th. Leerink Partners boosted their target price on Intuitive Surgical from $490.00 to $548.00 in a research note on Monday, January 27th. Bernstein Bank boosted their target price on Intuitive Surgical from $655.00 to $700.00 and gave the company an “overweight” rating in a research note on Monday, January 27th. Evercore ISI cut their target price on Intuitive Surgical from $510.00 to $470.00 and set an “in-line” rating on the stock in a research note on Wednesday, April 23rd. Finally, Jefferies Financial Group boosted their target price on Intuitive Surgical from $475.00 to $575.00 in a research note on Monday, January 27th. Five analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $598.95.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.